128133 20241125101145.0 doi 10.3389/fvets.2023.1176772 sideral 135282 ART-2023-135282 eng Barrachina, Laura Universidad de Zaragoza (orcid)0000-0001-9818-508X Induced pluripotent stem cells in companion animals: how can we move the field forward? 2023 Access copy available to the general public Unrestricted Following a one medicine approach, the development of regenerative therapies for human patients leads to innovative treatments for animals, while pre-clinical studies on animals provide knowledge to advance human medicine. Among many different biological products under investigation, stem cells are among the most prominent. Mesenchymal stromal cells (MSCs) are extensively investigated, but they present challenges such as senescence and limited differentiation ability. Embryonic stem cells (ESCs) are pluripotent cells with a virtually unlimited capacity for self-renewal and differentiation, but the use of embryos carries ethical concerns. Induced pluripotent stem cells (iPSCs) can overcome all of these limitations, as they closely resemble ESCs but are derived from adult cells by reprogramming in the laboratory using pluripotency-associated transcription factors. iPSCs hold great potential for applications in therapy, disease modeling, drug screening, and even species preservation strategies. However, iPSC technology is less developed in veterinary species compared to human. This review attempts to address the specific challenges associated with generating and applying iPSCs from companion animals. Firstly, we discuss strategies for the preparation of iPSCs in veterinary species and secondly, we address the potential for different applications of iPSCs in companion animals. Our aim is to provide an overview on the state of the art of iPSCs in companion animals, focusing on equine, canine, and feline species, as well as to identify which aspects need further optimization and, where possible, to provide guidance on future advancements. Following a “step-by-step” approach, we cover the generation of iPSCs in companion animals from the selection of somatic cells and the reprogramming strategies, to the expansion and characterization of iPSCs. Subsequently, we revise the current applications of iPSCs in companion animals, identify the main hurdles, and propose future paths to move the field forward. Transferring the knowledge gained from human iPSCs can increase our understanding in the biology of pluripotent cells in animals, but it is critical to further investigate the differences among species to develop specific approaches for animal iPSCs. This is key for significantly advancing iPSC application in veterinary medicine, which at the same time will also allow gaining pre-clinical knowledge transferable to human medicine. info:eu-repo/grantAgreement/EC/H2020/101026825/EU/Cartilage derived from equine induced pluripotent stem cells: an in vitro and ex vivo One Medicine approach for osteoarthritis/CAREQiPSC This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 101026825-CAREQiPSC info:eu-repo/semantics/openAccess by http://creativecommons.org/licenses/by/3.0/es/ 2.6 2023 VETERINARY SCIENCES 22 / 167 = 0.132 2023 Q1 T1 0.734 2023 Veterinary (miscellaneous) 2023 Q1 4.8 2023 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Arshaghi Eslami, Tarlan O'Brien, Aisling Ivanovska, Ana Barry, Frank 1001 420 Universidad de Zaragoza Dpto. Anatom.,Embri.Genét.Ani. Área Genética 10 (2023), 1176772 [18 pp.] Front. vet. sci. Frontiers in Veterinary Science 2297-1769 2136460 http://zaguan.unizar.es/record/128133/files/texto_completo.pdf Versión publicada 2135091 http://zaguan.unizar.es/record/128133/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:128133 articulos driver 2024-11-22-12:04:08 ARTICLE